<DOC>
	<DOCNO>NCT01504724</DOCNO>
	<brief_summary>This study investigate effect adjunctive intravitreal bevacizumab ( IVB ) panretinal photocoagulation ( PRP ) compare PRP central macular thickness retinal nerve fiber layer thickness patient severe diabetic retinopathy without macular edema .</brief_summary>
	<brief_title>Effect Adjunctive IVB Before PRP</brief_title>
	<detailed_description>This prospective randomized study include 30 patient ( 60 eye ) severe nonproliferative diabetic retinopathy non-high-risk proliferative diabetic retinopathy . They weekly PRP treatment 3 session randomly assign IVB group adjunctive IVB within 1 week first PRP control group PRP . CMT , RNFL , best-corrected visual acuity ( BCVA ) measure</detailed_description>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>patient severe NPDR early PDR without macular edema bestcorrected visual acuity ( BCVA ) 20/25 good patient follow least 6 month first PRP . patient retinal choroidal disease except diabetic retinopathy contraindication fluorescein angiography ( FA ) bevacizumab patient previous treatment include antiangiogenic medication laser photocoagulation patient previous vitrectomy patient uncontrolled hypertension , recent myocardial infarction cerebral vascular accident .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>central macular thickness</keyword>
</DOC>